Family Office Of America (FOFA) Current Assets (2021 - 2026)
Family Office Of America (FOFA) reported Current Assets of $668579.0 for Q1 2026, up 17.2% on a YoY basis from $570468.0 in Q1 2025, and up 147.29% sequentially from $270359.0 in Q4 2025.
Family Office Of America (FOFA) Current Assets (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Current Assets data on file, last reported at $668579.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 17.2% year-over-year to $668579.0; the trailing twelve-month figure through Mar 2026 stood at $668579.0 (up 17.2% YoY), and the FY2025 full-year result was $270359.0, up 1213.63% from the prior year.
- Current Assets advanced to $668579.0 in Q1 2026, from $270359.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $829347.0 in Q3 2025 to a low of $2431.0 in Q4 2023.
- A 5-year average of $283453.2 and a median of $202691.5 in 2022 frame the typical range for Current Assets.
- Across the five-year window, Current Assets tumbled 99.05% in 2023 and jumped 1675.75% in 2025, its largest moves.
- Tracing FOFA's Current Assets over 5 years: stood at $256203.0 in 2022, then plunged by 99.05% to $2431.0 in 2023, then jumped by 746.61% to $20581.0 in 2024, then surged by 1213.63% to $270359.0 in 2025, then jumped by 147.29% to $668579.0 in 2026.
- Business Quant data shows FOFA's Current Assets at $668579.0 in Q1 2026, $270359.0 in Q4 2025, and $829347.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 4.33 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.43 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 4.10 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 11.45 Bn |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 668,579.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 668,579.00 |
| Dec 31, 2025 | 270,359.00 |
| Sep 30, 2025 | 829,347.00 |
| Jun 30, 2025 | 588,771.00 |
| Mar 31, 2025 | 570,468.00 |
| Dec 31, 2024 | 20,581.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 63,456.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 95,506.00 |
| Jun 30, 2023 | 118,802.00 |
| Mar 31, 2023 | 149,180.00 |
| Dec 31, 2022 | 256,203.00 |
| Sep 30, 2022 | 409,665.00 |
| Jun 30, 2022 | 354,628.00 |
| Dec 31, 2021 | 743,703.00 |